Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

NCT07516366 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

NIH

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Stage II Renal Cell Cancer AJCC v8
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8

Interventions

BIOLOGICAL: Balstilimab
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Botensilimab
PROCEDURE: Computed Tomography
PROCEDURE: Nephrectomy
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)